BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 31578760)

  • 1. What are the statistical implications of treatment non-compliance in cluster randomized trials: A simulation study.
    Moerbeek M; Schie SV
    Stat Med; 2019 Nov; 38(26):5071-5084. PubMed ID: 31578760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How large are the consequences of covariate imbalance in cluster randomized trials: a simulation study with a continuous outcome and a binary covariate at the cluster level.
    Moerbeek M; van Schie S
    BMC Med Res Methodol; 2016 Jul; 16():79. PubMed ID: 27401771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cluster randomized crossover trial: The effects of attrition in the AB/BA design and how to account for it in sample size calculations.
    Moerbeek M
    Clin Trials; 2020 Aug; 17(4):420-429. PubMed ID: 32191129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intention-to-treat analysis in cluster randomized trials with noncompliance.
    Jo B; Asparouhov T; Muthén BO
    Stat Med; 2008 Nov; 27(27):5565-77. PubMed ID: 18623608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimating treatment effects in randomised controlled trials with non-compliance: a simulation study.
    Ye C; Beyene J; Browne G; Thabane L
    BMJ Open; 2014 Jun; 4(6):e005362. PubMed ID: 24939814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of confidence interval methods for the intraclass correlation coefficient in community-based cluster randomization trials with a binary outcome.
    Braschel MC; Svec I; Darlington GA; Donner A
    Clin Trials; 2016 Apr; 13(2):180-7. PubMed ID: 26415500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regaining power lost by non-compliance via full probability modelling.
    Becque T; White IR
    Stat Med; 2008 Nov; 27(27):5640-63. PubMed ID: 18712776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of confidence interval methods for the intraclass correlation coefficient in cluster randomized trials.
    Ukoumunne OC
    Stat Med; 2002 Dec; 21(24):3757-74. PubMed ID: 12483765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A readily available improvement over method of moments for intra-cluster correlation estimation in the context of cluster randomized trials and fitting a GEE-type marginal model for binary outcomes.
    Westgate PM
    Clin Trials; 2019 Feb; 16(1):41-51. PubMed ID: 30295512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The problem of measurement error in modelling the effect of compliance in a randomized trial.
    Dunn G
    Stat Med; 1999 Nov; 18(21):2863-77. PubMed ID: 10523747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimating causal effects from a randomized clinical trial when noncompliance is measured with error.
    Boatman JA; Vock DM; Koopmeiners JS; Donny EC
    Biostatistics; 2018 Jan; 19(1):103-118. PubMed ID: 28605411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interval estimation of the risk difference in non-compliance randomized trials with repeated binary measurements.
    Lui KJ
    Stat Med; 2007 Jul; 26(16):3140-56. PubMed ID: 17177272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of non-compliance on intent-to-treat analysis of equivalence trials.
    Sheng D; Kim MY
    Stat Med; 2006 Apr; 25(7):1183-99. PubMed ID: 16220491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Power and money in cluster randomized trials: when is it worth measuring a covariate?
    Moerbeek M
    Stat Med; 2006 Aug; 25(15):2607-17. PubMed ID: 16217840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of model- and design-based approaches to detect the treatment effect and covariate by treatment interactions in three-level models for multisite cluster-randomized trials.
    Aydin B; Algina J; L Leite W
    Behav Res Methods; 2019 Feb; 51(1):243-257. PubMed ID: 30066262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intra-cluster correlation selection for cluster randomized trials.
    Westgate PM
    Stat Med; 2016 Aug; 35(19):3272-84. PubMed ID: 26924419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Augmented generalized estimating equations for improving efficiency and validity of estimation in cluster randomized trials by leveraging cluster-level and individual-level covariates.
    Stephens AJ; Tchetgen Tchetgen EJ; De Gruttola V
    Stat Med; 2012 May; 31(10):915-30. PubMed ID: 22359361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficiency and robustness of causal effect estimators when noncompliance is measured with error.
    Boatman JA; Vock DM; Koopmeiners JS
    Stat Med; 2018 Dec; 37(28):4126-4141. PubMed ID: 30109713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of the statistical power of different methods for the analysis of cluster randomization trials with binary outcomes.
    Austin PC
    Stat Med; 2007 Aug; 26(19):3550-65. PubMed ID: 17238238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Model mis-specification and overestimation of the intraclass correlation coefficient in cluster randomized trials.
    Giraudeau B
    Stat Med; 2006 Mar; 25(6):957-64. PubMed ID: 15977300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.